1k62
From Proteopedia
(New page: 200px<br /> <applet load="1k62" size="450" color="white" frame="true" align="right" spinBox="true" caption="1k62, resolution 2.65Å" /> '''Crystal Structure o...) |
|||
Line 1: | Line 1: | ||
- | [[Image:1k62.gif|left|200px]]<br /> | + | [[Image:1k62.gif|left|200px]]<br /><applet load="1k62" size="350" color="white" frame="true" align="right" spinBox="true" |
- | <applet load="1k62" size=" | + | |
caption="1k62, resolution 2.65Å" /> | caption="1k62, resolution 2.65Å" /> | ||
'''Crystal Structure of the Human Argininosuccinate Lyase Q286R Mutant'''<br /> | '''Crystal Structure of the Human Argininosuccinate Lyase Q286R Mutant'''<br /> | ||
==Overview== | ==Overview== | ||
- | Argininosuccinate lyase (ASL) catalyzes the reversible breakdown of | + | Argininosuccinate lyase (ASL) catalyzes the reversible breakdown of argininosuccinate to arginine and fumarate, a reaction involved in the biosynthesis of arginine in all species and in the production of urea in ureotelic species. In humans, mutations in the enzyme result in the autosomal recessive disorder argininosuccinic aciduria. Intragenic complementation has been demonstrated to occur at the ASL locus, with two distinct classes of ASL-deficient strains having been identified, the frequent and high-activity complementers. The frequent complementers participate in the majority of the complementation events observed and were found to be either homozygous or heterozygous for a glutamine to arginine mutation at residue 286. The three-dimensional structure of the frequently complementing allele Q286R has been determined at 2.65 A resolution. This is the first high-resolution structure of human ASL. Comparison of this structure with the structures of wild-type and mutant duck delta1 and delta2 crystallins suggests that the Q286R mutation may sterically and/or electrostatically hinder a conformational change in the 280's loop (residues 270-290) and domain 3 that is thought to be necessary for catalysis to occur. The comparison also suggests that residues other than R33, F333, and D337 play a role in maintaining the structural integrity of domain 1 and reinforces the suggestion that residues 74-89 require a particular conformation for catalysis. The electron density has enabled the structure of residues 6-18 to be modeled for the first time. Residues 7-9 and 15-18 are in type IV beta-turns and are connected by a loop. The conformation observed is stabilized, in part, by a salt bridge between the side chains of R12 and D18. Although the disease causing mutation R12Q would disrupt this salt bridge, it is unclear why this mutation has such a significant effect on the catalytic activity as residues 1-18 are disordered in all other delta-crystallin structures determined to date. |
==Disease== | ==Disease== | ||
Line 11: | Line 10: | ||
==About this Structure== | ==About this Structure== | ||
- | 1K62 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Active as [http://en.wikipedia.org/wiki/Lyase Lyase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=4.3.2.1. 4.3.2.1.] Full crystallographic information is available from [http:// | + | 1K62 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Active as [http://en.wikipedia.org/wiki/Lyase Lyase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=4.3.2.1. 4.3.2.1.] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1K62 OCA]. |
==Reference== | ==Reference== | ||
Line 18: | Line 17: | ||
[[Category: Lyase]] | [[Category: Lyase]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
- | [[Category: Howell, P | + | [[Category: Howell, P L.]] |
- | [[Category: Sampaleanu, L | + | [[Category: Sampaleanu, L M.]] |
- | [[Category: Thompson, G | + | [[Category: Thompson, G D.]] |
[[Category: Vallee, F.]] | [[Category: Vallee, F.]] | ||
[[Category: arginiosuccinate lyase]] | [[Category: arginiosuccinate lyase]] | ||
Line 27: | Line 26: | ||
[[Category: intragenic complementation]] | [[Category: intragenic complementation]] | ||
- | ''Page seeded by [http:// | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:30:31 2008'' |
Revision as of 11:30, 21 February 2008
|
Crystal Structure of the Human Argininosuccinate Lyase Q286R Mutant
Contents |
Overview
Argininosuccinate lyase (ASL) catalyzes the reversible breakdown of argininosuccinate to arginine and fumarate, a reaction involved in the biosynthesis of arginine in all species and in the production of urea in ureotelic species. In humans, mutations in the enzyme result in the autosomal recessive disorder argininosuccinic aciduria. Intragenic complementation has been demonstrated to occur at the ASL locus, with two distinct classes of ASL-deficient strains having been identified, the frequent and high-activity complementers. The frequent complementers participate in the majority of the complementation events observed and were found to be either homozygous or heterozygous for a glutamine to arginine mutation at residue 286. The three-dimensional structure of the frequently complementing allele Q286R has been determined at 2.65 A resolution. This is the first high-resolution structure of human ASL. Comparison of this structure with the structures of wild-type and mutant duck delta1 and delta2 crystallins suggests that the Q286R mutation may sterically and/or electrostatically hinder a conformational change in the 280's loop (residues 270-290) and domain 3 that is thought to be necessary for catalysis to occur. The comparison also suggests that residues other than R33, F333, and D337 play a role in maintaining the structural integrity of domain 1 and reinforces the suggestion that residues 74-89 require a particular conformation for catalysis. The electron density has enabled the structure of residues 6-18 to be modeled for the first time. Residues 7-9 and 15-18 are in type IV beta-turns and are connected by a loop. The conformation observed is stabilized, in part, by a salt bridge between the side chains of R12 and D18. Although the disease causing mutation R12Q would disrupt this salt bridge, it is unclear why this mutation has such a significant effect on the catalytic activity as residues 1-18 are disordered in all other delta-crystallin structures determined to date.
Disease
Known disease associated with this structure: Argininosuccinic aciduria OMIM:[608310]
About this Structure
1K62 is a Single protein structure of sequence from Homo sapiens. Active as Lyase, with EC number 4.3.2.1. Full crystallographic information is available from OCA.
Reference
Three-dimensional structure of the argininosuccinate lyase frequently complementing allele Q286R., Sampaleanu LM, Vallee F, Thompson GD, Howell PL, Biochemistry. 2001 Dec 25;40(51):15570-80. PMID:11747432
Page seeded by OCA on Thu Feb 21 13:30:31 2008